David W Green

This inventor holds 5 USPTO granted patents. Top assignee: Smithkline Beecham Corporation. Active years: 1998-2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David W Green. Retrieved from https://idiyas.com/inventor/david-w-green-o9q1d0jj

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 5

% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 5

Forward Citations = 131(Granted Patents)

Company Filing History:

5 out of 2,198

Smithkline Beecham Corporation

patents

Years Active: 1998-2002

Loading Chart...

5 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6361773 - Antibodies produced against cytokine suppressive anti-inflammatory drug binding proteins (2002-03-26),

2. 5955366 - Polynucleotides encoding cytokine suppressive anti-inflammatory drug (1999-09-21),

3. 5871934 - Screening methods using cytokine suppressive anti-inflammatory drug (1999-02-16),

4. 5783664 - Cytokine suppressive anit-inflammatory drug binding proteins (1998-07-21),

5. 5777097 - Oligonucleotides comprising a region of a cytokine suppressive (1998-07-07),

Title: Innovator Spotlight: David W Green - Pioneering Drug Binding Proteins

Introduction:

Meet David W Green, a brilliant inventor based in Bryn Mawr, PA (US), with an impressive portfolio of 5 patents under his belt. His groundbreaking work in the field of drug binding proteins has revolutionized pharmaceutical research and development.

Latest Patents:

David W Green's latest patents showcase his expertise in the realm of Cytokine Suppressive Anti-Inflammatory Drug (CSAID) binding proteins. These patents focus on the development of drug binding proteins, genes encoding the same, and innovative assays for screening pharmaceuticals. Specifically, his inventions highlight the significance of CSAID binding proteins in the evaluation and characterization of drugs belonging to this pharmacologic class.

Career Highlights:

Currently, David W Green is a key member of the renowned SmithKline Beecham Corporation, where he continues to push the boundaries of innovation in the pharmaceutical industry. His contributions have not only earned him recognition within the company but also garnered widespread acclaim in the scientific community.

Collaborations:

Within SmithKline Beecham Corporation, David W Green collaborates closely with esteemed colleagues such as Jerry Leroy Adams and Timothy Francis Gallagher. Together, they form a dynamic team driving forward cutting-edge research and development initiatives in the field of drug discovery.

Conclusion:

In conclusion, David W Green stands as a true trailblazer in the realm of drug binding proteins, with a remarkable track record of patented inventions that have reshaped the landscape of pharmaceuticals. His unwavering dedication to innovation and collaboration continues to inspire the next generation of inventors in the pursuit of transformative discoveries.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]